Maryland’s Rich History of Regenerative Medicine

Maryland is home to one of the first concentrated autologous mesenchymal stem cell (MSC) products for regenerative bone growth named Osteocel, developed by Osiris Technologies. The company was later sold to Smith & Nephew – who still operate out of Columbia, MD, today – and Osteocel became a prime candidate for reproduction into more commercialized venues. This is just one success story of Maryland’s innovation in regenerative medicine. Regardless of the proprietor, products like Osteocel continue to flourish from Maryland, and many of these business blooms are transpired by accelerators such as Launchport located in Baltimore’s Port Covington.